biotech Value proposition
Leading the way in Europe to bring microbiome-based innovations to market
APM gathers more than 20 key players from public and private sectors: Bioaster, Biocodex, Biofortis, Biose Industrie, Cynbiose, Cynbiome, Eligo Bioscience, EverImmune, GMT, INRAE, INSERM, Lallemand, Luxia, LyonBiopôle, MaaT Pharma, Medicen, Microbiome Fundation, Nexbiome, Novobiome, Seventure Partners, Stellate Therapeutics, Skyepharma, TargEDys.
Leading the way in Europe to bring microbiome-based innovations to market.
Created in 2022, Alliance Promotion Microbiote is an independent, non-profit organization. Our goal is to position France as the European leader in the development, production, and commercialization of therapeutic microbiome-based innovations.
APM gathers more than 20 key players from public and private sectors. From bench to bedside, APM encompasses the entire value chain of the microbiome industry.
We work to accelerate the translation of basic research towards market launch of microbiome-based innovations, to meet important medical needs and improve the quality-of-life of millions of patients.
microbiome, research, clinical development, public, private, microbiota, and R&DOriginal language
Leading the way in Europe to bring microbiome-based innovations to market
APM gathers more than 20 key players from public and private sectors: Bioaster, Biocodex, Biofortis, Biose Industrie, Cynbiose, Cynbiome, Eligo Bioscience, EverImmune, GMT, INRAE, INSERM, Lallemand, Luxia, LyonBiopôle, MaaT Pharma, Medicen, Microbiome Fundation, Nexbiome, Novobiome, Seventure Partners, Stellate Therapeutics, Skyepharma, TargEDys.
Leading the way in Europe to bring microbiome-based innovations to market.
Created in 2022, Alliance Promotion Microbiote is an independent, non-profit organization. Our goal is to position France as the European leader in the development, production, and commercialization of therapeutic microbiome-based innovations.
APM gathers more than 20 key players from public and private sectors. From bench to bedside, APM encompasses the entire value chain of the microbiome industry.
We work to accelerate the translation of basic research towards market launch of microbiome-based innovations, to meet important medical needs and improve the quality-of-life of millions of patients.
APM - Driving Microbiome Industry in France
APM accelerates microbiome research, attracts investment & promotes innovative therapies in France. Join us to position France as a global microbiome leader.
https://frenchmicrobiome.org/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 grandlyon National and local authorities, Government Administration, French metropolis | grandlyon National and local authorities, Government Administration, French metropolis | Other 24 Feb 2024 | | |
 INRAE Research, Research Services | INRAE Research, Research Services | Other 27 Mar 2024 | | |
 Seventure Partners Startup accelerator & VC, Venture Capital and Private Equity Principals | Seventure Partners Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 27 Mar 2024 | | |
 Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Other 27 Mar 2024 | | |
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 25 Sep 2023 | | |
 Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 27 Mar 2024 | | |